Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
58,378,537
-
Shares change
-
+286,713
-
Total reported value, excl. options
-
$2,626,676,199
-
Value change
-
+$33,782,408
-
Put/Call ratio
-
76.4%
-
Number of buys
-
95
-
Number of sells
-
-80
-
Price
-
$45.00
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2019
219 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2019.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58,378,537 shares
of 80,437,135 outstanding shares and own 72.58% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,070,674 shares), BlackRock Inc. (4,502,671 shares), FRANKLIN RESOURCES INC (4,188,140 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,867,289 shares), RTW INVESTMENTS, LP (3,137,361 shares), Point72 Asset Management, L.P. (2,652,447 shares), FMR LLC (2,374,442 shares), STATE STREET CORP (2,313,768 shares), ORBIMED ADVISORS LLC (2,089,700 shares), and GREAT POINT PARTNERS LLC (1,974,385 shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.